Lam Research 10-Q 2022-12-25
Filed 2023-01-30. 8 sections, 226K characters. Original on sec.gov · Markdown · JSON
Cover and table of contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
| ☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended December 25, 2022
or
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number 0-12933
LAM RESEARCH CORPORATION
(Exact name of registrant as specified in its charter)
| Delaware | 94-2634797 | |||||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
| 4650 Cushing Parkway, | Fremont, | California | 94538 |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (510) 572-0200
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
| Common Stock, Par Value $0.001 Per Share | LRCX | The Nasdaq Stock Market | ||||||
| (Nasdaq Global Select Market) |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☒ | Accelerated filer | ☐ | |||||||||||||||||
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ | |||||||||||||||||
| Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of January 26, 2023, the Registrant had 134,936,209 shares of Common Stock outstanding.
LAM RESEARCH CORPORATION
TABLE OF CONTENTS
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited)
| Three Months Ended | Six Months Ended | ||||||||||||||||||||||
| December 25, 2022 | December 26, 2021 | December 25, 2022 | December 26, 2021 | ||||||||||||||||||||
| Revenue | $ | 5,277,569 | $ | 4,226,604 | $ | 10,351,690 | $ | 8,531,069 | |||||||||||||||
| Cost of goods sold | 2,901,220 | 2,248,688 | 5,638,506 | 4,576,399 | |||||||||||||||||||
| Gross margin | 2,376,349 | 1,977,916 | 4,713,184 | 3,954,670 | |||||||||||||||||||
| Research and development | 462,385 | 403,644 | 895,760 | 785,971 | |||||||||||||||||||
| Selling, general, and administrative | 233,802 | 236,133 | 439,422 | 458,327 | |||||||||||||||||||
| Total operating expenses | 696,187 | 639,777 | 1,335,182 | 1,244,298 | |||||||||||||||||||
| Operating income | 1,680,162 | 1,338,139 | 3,378,002 | 2,710,372 | |||||||||||||||||||
| Other income (expense), net | (28,234) | 17,999 | (71,329) | (10,858) | |||||||||||||||||||
| Income before income taxes | 1,651,928 | 1,356,138 | 3,306,673 | 2,699,514 | |||||||||||||||||||
| Income tax expense | (183,421) | (161,308) | (412,287) | (324,940) | |||||||||||||||||||
| Net income | $ | 1,468,507 | $ | 1,194,830 | $ | 2,894,386 | $ | 2,374,574 | |||||||||||||||
| Net income per share: | |||||||||||||||||||||||
| Basic | $ | 10.80 | $ | 8.50 | $ | 21.21 | $ | 16.82 | |||||||||||||||
| Diluted | $ | 10.77 | $ | 8.44 | $ | 21.16 | $ | 16.71 | |||||||||||||||
| Number of shares used in per share calculations: | |||||||||||||||||||||||
| Basic | 136,018 | 140,630 | 136,455 | 141,187 | |||||||||||||||||||
| Diluted | 136,339 | 141,530 | 136,774 | 142,071 | |||||||||||||||||||
See Notes to Condensed Consolidated Financial Statements
Lam Research Corporation 2023 Q2 10-Q 3
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in thousands)
(unaudited)
| Three Months Ended | Six Months Ended | ||||||||||||||||||||||
| December 25, 2022 | December 26, 2021 | December 25, 2022 | December 26, 2021 | ||||||||||||||||||||
| Net income | $ | 1,468,507 | $ | 1,194,830 | $ | 2,894,386 | $ | 2,374,574 | |||||||||||||||
| Other comprehensive income (loss), net of tax: | |||||||||||||||||||||||
| Foreign currency translation adjustment | 41,470 | (9,820) | 7,861 | (13,852) | |||||||||||||||||||
| Cash flow hedges: | |||||||||||||||||||||||
| Net unrealized (losses) gains during the period | (18,618) | 12,792 | 185 | 3,787 | |||||||||||||||||||
| Net losses (gains) reclassified into net income | 1,273 | (7,904) | (8,024) | (11,446) | |||||||||||||||||||
| (17,345) | 4,888 | (7,839) | (7,659) | ||||||||||||||||||||
| Available-for-sale investments: | |||||||||||||||||||||||
| Net unrealized gains (losses) during the period | 490 | (785) | 570 | (3,190) | |||||||||||||||||||
| Net losses (gains) reclassified into net income | — | 345 | (53) | 1,490 | |||||||||||||||||||
| 490 | (440) | 517 | (1,700) | ||||||||||||||||||||
| Defined benefit plans, net change in unrealized component | 279 | (1,006) | 572 | (807) | |||||||||||||||||||
| Other comprehensive income (loss), net of tax | 24,894 | (6,378) | 1,111 | (24,018) | |||||||||||||||||||
| Comprehensive income | $ | 1,493,401 | $ | 1,188,452 | $ | 2,895,497 | $ | 2,350,556 | |||||||||||||||
See Notes to Condensed Consolidated Financial Statements
Lam Research Corporation 2023 Q2 10-Q 4
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except per share data)
| December 25, 2022 | June 26, 2022 | ||||||||||
| (unaudited) | (1) | ||||||||||
| ASSETS | |||||||||||
| Cash and cash equivalents | $ | 4,484,716 | $ | 3,522,001 | |||||||
| Investments | 103,130 | 135,731 | |||||||||
| Accounts receivable, less allowance of $5,411 as of December 25, 2022, and $5,606 as of June 26, 2022 | 4,070,088 | 4,313,818 | |||||||||
| Inventories | 4,819,966 | 3,966,294 | |||||||||
| Prepaid expenses and other current assets | 230,888 | 347,391 | |||||||||
| Total current assets | 13,708,788 | 12,285,235 | |||||||||
| Property and equipment, net | 1,863,155 | 1,647,587 | |||||||||
| Restricted cash and investments | 251,344 | 251,534 | |||||||||
| Goodwill | 1,620,437 | 1,515,113 | |||||||||
| Intangible assets, net | 184,781 | 101,850 | |||||||||
| Other assets | 1,577,876 | 1,394,313 | |||||||||
| Total assets | $ | 19,206,381 | $ | 17,195,632 | |||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||
| Trade accounts payable | $ | 919,408 | $ | 1,011,208 | |||||||
| Accrued expenses and other current liabilities | 2,068,370 | 1,974,272 | |||||||||
| Deferred profit | 1,551,918 | 1,571,898 | |||||||||
| Current portion of long-term debt and finance lease obligations | 7,226 | 7,381 | |||||||||
| Total current liabilities | 4,546,922 | 4,564,759 | |||||||||
| Long-term debt and finance lease obligations, less current portion | 4,996,057 | 4,998,449 | |||||||||
| Income taxes payable | 862,405 | 931,117 | |||||||||
| Other long-term liabilities | 496,362 | 422,941 | |||||||||
| Total liabilities | 10,901,746 | 10,917,266 | |||||||||
| Commitments and contingencies | |||||||||||
| Stockholders’ equity: | |||||||||||
| Preferred stock, at par value of $0.001 per share; authorized, 5,000 shares, no |
Showing the first 8K of 95K characters. Open the full section
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
With the exception of historical facts, the statements contained in this discussion are forward-looking statements, which are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Certain, but not all, of the forward-looking statements in this report are specifically identified as forward-looking, by use of phrases and words such as “believe,” “estimated,” “anticipate,” “expect,” “probable,” “intend,” “plan,” “aim,” “may,” “should,” “could,” “would,” “will,” “continue,” and other future-oriented terms. The identification of certain statements as “forward-looking” does not mean that other statements not specifically identified are not forward-looking. Forward-looking statements include but are not limited to statements that relate to: trends and opportunities in the global economic environment; trends and opportunities in the semiconductor industry, including in the end markets and applications for semiconductors, and in device complexity; growth or decline in the industry and the market for, and spending on, wafer fabrication equipment; the anticipated levels of, and rates of change in, margins, market share, served addressable market, capital expenditures, research and development expenditures, international sales, revenue (actual and/or deferred), operating expenses and earnings generally; management’s plans and objectives for our current and future operations and business focus; volatility in our quarterly results; the makeup of our customer base; customer and end user requirements and our ability to satisfy those requirements; customer spending and demand for our products and services, and the reliability of indicators of change in customer spending and demand; the effect of variability in our customers’ business plans or demand for our products and services; our competition, and our ability to defend our market share and to gain new market share; the success of joint development and collaboration relationships with customers, suppliers, or others; outsourced activities; our supply chain and the role of suppliers in our business, including the impacts of supply chain constraints and material costs; our leadership and competency, and our ability to facilitate innovation; our research and development programs; our ability to create sustainable differentiation; technology inflections in the industry and our ability to identify those inflections and to invest in research and development programs to meet them; our ability to deliver multi-product solutions; the resources invested to comply with evolving standards and the impact of such efforts; changes in state, federal and international tax laws, our estimated annual tax rate and the factors that affect our tax rates; legal and regulatory compliance; the estimates we make, and the accruals we record, in order to implement our critical accounting policies (including but not limited to the adequacy of prior tax payments, future tax benefits or liabilities, and the adequacy of our accruals relating to them); hedging transactions; debt or financing arrangements; our investment portfolio; our access to capital markets; uses of, payments of, and impact of interest rate fluctuations on, our debt; our intention to pay quarterly dividends and the amounts thereof, if any; our ability and intention to repurchase our shares; credit risks; controls and procedures; recognition or amortization of expenses; our ability to manage and grow our cash position; our strategic relevance with our customers; our ability to scale our operations to respond to changes in our business; the value of our patents; the materiality of potential losses arising from legal proceedings; the probability of making payments under our guarantees; the impact of the COVID-19 pandemic; and the sufficiency of our financial resources or liquidity to support future business activities (including but not limited to operations, investments, debt service requirements, dividends, and capital expenditures). Such statements are based on current expectations and are subject to risks, uncertainties, and changes in condition, significance, value, and effect, including without limitation those discussed below under the heading “Risk Factors” within Part II Item 1A and elsewhere in this report and other documents we file from time to time with the Securities and Exchange Commission (“SEC”), such as our annual report on Form 10-K for the year ended June 26, 2022 (our “2022 Form 10-K”), our quarterly report on Form 10-Q for the fiscal quarter ended September 25, 2022, and our current reports on Form 8-K. Such risks, uncertainties, and changes in condition, significance, value, and effect could cause our actual results to differ materially from those expressed in this report and in ways not readily foreseeable. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof and are based on information currently and reasonably known to us. We do not undertake any obligation to release the results of any revisions to these forward-looking statements, which may be made to reflect events or circumstances that occur after the date of this report or to reflect the occurrence or effect of anticipated or unanticipated events.
Documents To Review In Connection With Management’s Discussion and Analysis Of Financial Condition and Results Of Operations
For a full understanding of our financial position and results of operations for the three and six months ended December 25, 2022, and the related Management’s Discussion and Analysis of Financial Condition and Results of Operations below, you should also read the Condensed Consolidated Financial Statements and notes presented in this Form 10-Q and the financial statements and notes in our 2022 Form 10-K.
Lam Research Corporation 2023 Q2 10-Q 21
EXECUTIVE SUMMARY
Lam Research Corporation is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. We have built a strong global presence with core competencies in areas like nanoscale applications enablement, chemistry, plasma and fluidics, advanced systems engineering and a broad range of operational disciplines. Our products and services are designed to help our customers build smaller and better performing devices that are used in a variety of electronic products, including mobile phones, personal computers, servers, wearables, automotive vehicles, and data storage devices.
Our customer base includes leading semiconductor memory, foundry, and integrated device manufacturers that make products such as non-volatile memory, dynamic random-access memory, and logic devices. Their continued success is part of our commitment to driving semiconductor breakthroughs that define the next generation. Our core technical competency is integrating hardware, process, materials, software, and process control, enabling results on the wafer.
Semiconductor manufacturing, our customers’ business, involves the complete fabrication of multiple dies or integrated circuits on a wafer. This involves the repetition of a set of core processes and can require hundreds of individual steps. Fabricating these devices requires highly sophisticated process technologies to integrate an increasing array of new materials with precise control at the atomic scale. Along with meeting technical requirements, wafer processing equipment must deliver high productivity and be cost-effective.
Demand from cloud computing, 5G, the Internet of Things, and other markets is driving the need for increasingly powerful and cost-efficient semiconductors. At the same time, there are growing technical challenges with traditional two-dimensional scaling. These trends are driving significant inflections in semiconductor manufacturing, such as the increasing importance of vertical scaling strategies like three-dimensional architecture as well as multiple patterning to enable shrinks.
We believe we are in a strong position with our leadership and expertise in deposition, etch, and clean to facilitate some of the most significant innovations in semiconductor device manufacturing. Our Customer Support Business Group provides products and services to maximize installed equipment performance, predictability, and operational efficiency. Several factors create opportunity for sustainable differentiation for us: (i) our focus on research and development, with several on-going programs relating to sustaining engineering, product and process development, and concept and feasibility; (ii) our ability to effectively leverage cycles of learning from our broad installed base; (iii) our collaborative focus with semi-ecosystem partners; (iv) our ability to identify and invest in the breadth of our product portfolio to meet technology inflections; and (v) our focus on delivering our multi-product solutions with a goal to enhance the value of Lam’s solutions to our customers.
Calendar year 2022 was a solid investment year in wafer fabrication equipment spending driven by robust secular demand for semiconductors and increasing complexity in manufacturing NAND, DRAM, and foundry logic devices. However, the demand environment, particularly in memory, has weakened, and as a result, we expect a reduction in wafer fabrication equipment spending in calendar year 2023. Additionally, the United States government imposed new controls which significantly impact trade with China for the shipment of wafer fabrication equipment and related parts and services. We expect these regulatory conditions, and the slowing economic environment, to negatively impact our financial results in calendar year 2023. As a result of the expected reduced business levels, we announced a plan for the March 2023 quarter to reduce headcount by 1,300 employees, and we expect to incur charges of approximately $80.0 million in connection with the plan. Over the course of calendar year 2023, we are projecting expenditures in the range of $150.0 million to $250.0 million associated with various business process improvements and initiatives, inclusive of the March 2023 quarter restructuring activity. Over the longer term, we believe that secular demand for semiconductors combined with technology inflections in our industry, including 3D device scaling, multiple patterning, process flow, and advanced packaging chip integration, will drive sustainable growth and lead to an increase in the served addressable market for our products and services in the deposition, etch, and clean businesses.
In the quarter-ended December 25, 2022, customer demand was strong and with improvement in supply chain constraints we were able to fulfill shipments of many critical parts required for revenue recognition. Although we have seen improvements in both our operations and those of our suppliers, we may continue to experience supply shortages as well as inflationary cost pressures in at least the near term. Risks and uncertainties related to the COVID-19 pandemic, supply chain challenges, and inflationary pressures may continue to negatively impact our revenue and gross margin.
Lam Research Corporation 2023 Q2 10-Q 22
The following table summarizes certain key financial information for the periods indicated below:
| Three Months Ended | |||||||||||||||||
| December 25, 2022 | September 25, 2022 | ||||||||||||||||
| (in thousands, except per share data and percentages) | |||||||||||||||||
| Revenue | $ | 5,277,569 | $ | 5,074,121 | |||||||||||||
| Gross margin | $ | 2,376,349 | $ | 2,336,835 | |||||||||||||
| Gross margin as a percent of total revenue | 45.0 | % | 46.1 | % | |||||||||||||
| Total operating expenses | $ | 696,187 | $ | 638,995 | |||||||||||||
| Net income | $ | 1,468,507 | $ | 1,425,879 | |||||||||||||
| Diluted net income per share | $ | 10.77 | $ | 10.39 |
In the December 2022 quarter, revenue increased 4.0% compared to the September 2022 quarter, driven by an increase in systems revenue as a result of the improving supply chain environment. We were able to fulfill shipments of critical parts which drove down our deferred revenue balance to $1,984 million at the end of the December 2022 quarter compared to $2,755 million as of the end of the September 2022 quarter. We aim to balance the requirements of our customers with the availability of resources, as well as performance to our operational and financial objectives. As a result, from time to time, we exercise discretion and judgment as to the timing and prioritization of manufacturing and deliveries of products, which has impacted, including in the current fiscal year, and may in the future impact, the timing of revenue recognition with respect to such products.
The decrease in gross margin as a percentage of revenue in the December 2022 quarter compared to the September 2022 quarter was primarily a result of unfavorable customer and product mix. The increase in operating expenses in the December 2022 quarter compared to the September 2022 quarter was primarily driven by an increase in deferred compensation plan-related costs, outside service spending and supplies expense.
Our cash and cash equivalents, investments, and restricted cash and investments balances increased to $4.8 billion at the end of the December 2022 quarter compared to $4.6 billion at the end of the September 2022 quarter. This increase was primarily the result of $1,140.2 million of cash generated from operating activities, partially offset by $456.3 million of share repurchases, including net share settlement of employee stock-based compensation, $236.0 million of dividends paid to stockholders; and $163.4 million of capital expenditures. Employee headcount as of December 25, 2022 was approximately 19,200.
RESULTS OF OPERATIONS
Revenue
| Three Months Ended | Six Months Ended | ||||||||||||||||||||||||||||
| December 25, 2022 | September 25, 2022 | December 25, 2022 | December 26, 2021 | ||||||||||||||||||||||||||
| Revenue (in millions) | $ | 5,278 | $ | 5,074 | $ | 10,352 | $ | 8,531 | |||||||||||||||||||||
| China | 24 | % | 30 | % | 27 | % | 31 | % | |||||||||||||||||||||
| Korea | 20 | % | 17 | % | 19 | % | 23 | % | |||||||||||||||||||||
| Taiwan | 19 | % | 22 | % | 20 | % | 17 | % | |||||||||||||||||||||
| Japan | 11 | % | 9 | % | 10 | % | 11 | % | |||||||||||||||||||||
| Southeast Asia | 10 | % | 11 | % | 10 | % | 9 | % | |||||||||||||||||||||
| United States | 10 | % | 6 | % | 8 | % | 6 | % | |||||||||||||||||||||
| Europe | 6 | % | 5 | % | 6 | % | 3 | % |
Revenue for the December 2022 quarter increased 4.0% from the September 2022 quarter primarily due to improving supply chain conditions which allowed us to fulfill shipments of critical parts.
Lam Research Corporation 2023 Q2 10-Q 23
The following table presents our revenue disaggregated between system and customer support-related revenue:
| Three Months Ended | Six Months Ended | ||||||||||||||||||||||||||||
| December 25, 2022 | September 25, 2022 | December 25, 2022 | December 26, 2021 | ||||||||||||||||||||||||||
| (In thousands) | |||||||||||||||||||||||||||||
| System revenue | $ | 3,547,518 | $ | 3,181,987 | $ | 6,729,505 | $ | 5,665,056 | |||||||||||||||||||||
| Customer support-related revenue and other | 1,730,051 | 1,892,134 | 3,622,185 | 2,866,013 | |||||||||||||||||||||||||
| $ | 5,277,569 | $ | 5,074,121 | $ | 10,351,690 | $ | 8,531,069 | ||||||||||||||||||||||
Please refer to Note 3, “Revenue,” to the Condensed Consolidated Financial Statements of this Form 10-Q for additional information regarding the composition of the two categories into which revenue has been disaggregated.
The following table presents the percentages of leading- and non-leading-edge equipment and upgrade revenue to each of the primary markets we serve:
| Three Months Ended | Six Months Ended | ||||||||||||||||||||||||||||
| December 25, 2022 | September 25, 2022 | December 25, 2022 | December 26, 2021 | ||||||||||||||||||||||||||
| Memory | 50 | % | 52 | % | 50 | % | 61 | % | |||||||||||||||||||||
| Foundry | 31 | % | 34 | % | 33 | % | 28 | % | |||||||||||||||||||||
| Logic/integrated device manufacturing | 19 | % | 14 | % | 17 | % | 11 | % |
The decrease in the memory market for the six months ended December 25, 2022 as compared to the same period in 2021, is primarily due to decreases in DRAM investments by our customers during this time period.
Gross Margin
| Three Months Ended | Six Months Ended | ||||||||||||||||||||||||||||
| December 25, 2022 | September 25, 2022 | December 25, 2022 | December 26, 2021 | ||||||||||||||||||||||||||
| (in thousands, except percentages) | |||||||||||||||||||||||||||||
| Gross margin | $ | 2,376,349 | $ | 2,336,835 | $ | 4,713,184 | $ | 3,954,670 | |||||||||||||||||||||
| Percent of revenue | 45.0 | % | 46.1 | % | 45.5 | % | 46.4 | % |
Gross margin as a percentage of revenue was lower in the December 2022 quarter compared to the September 2022 quarter primarily as a result of unfavorable customer and product mix.
The decrease in gross margin as a percentage of revenue in the six months ended December 25, 2022 compared to the same period in the prior year was primarily driven by higher levels of manufacturing-related spending as a result of increased inflationary pressures, partially offset by favorable customer and product mix.
Research and Development
| Three Months Ended | Six Months Ended | ||||||||||||||||||||||||||||
| December 25, 2022 | September 25, 2022 | December 25, 2022 | December 26, 2021 | ||||||||||||||||||||||||||
| (in thousands, except percentages) | |||||||||||||||||||||||||||||
| Research & development (“R&D”) | $ | 462,385 | $ | 433,375 | $ | 895,760 | $ | 785,971 | |||||||||||||||||||||
| Percent of revenue | 8.8 | % | 8.5 | % | 8.7 | % | 9.2 | % |
We continued to make significant R&D investments in the December 2022 quarter focused on leading-edge deposition, etch, clean and other semiconductor manufacturing processes. The increase in R&D expense in the December 2022 quarter compared to the September 2022 quarter was primarily driven by an increase of $14 million in spending for supplies and $11 million in deferred compensation plan-related costs.
The increase in R&D expense in the six months ended December 25, 2022 compared to the same period in the prior year was primarily driven by increases in employee-related expenses mainly as a result of increased headcount as well as for $32 million in spending for supplies.
Lam Research Corporation 2023 Q2 10-Q 24
Selling, General, and Administrative
| Three Months Ended | Six Months Ended | ||||||||||||||||||||||||||||
| December 25, 2022 | September 25, 2022 | December 25, 2022 | December 26, 2021 | ||||||||||||||||||||||||||
| (in thousands, except percentages) | |||||||||||||||||||||||||||||
| Selling, general, and administrative (“SG&A”) | $ | 233,802 | $ | 205,620 | $ | 439,422 | $ | 458,327 | |||||||||||||||||||||
| Percent of revenue | 4.4 | % | 4.1 | % | 4.2 | % | 5.4 | % |
SG&A expense during the December 2022 quarter increased in comparison to the September 2022 quarter, primarily driven by an increase of $14 million in outside service spending.
SG&A expense during the six months ended December 25, 2022 decreased compared to the same period in the prior year, primarily driven by a decrease of $23 million in amortization for intangible assets, as the intangible assets associated with our Novellus Systems, Inc. transactions have fully amortized.
Other Income (Expense), Net
Other income (expense), net consisted of the following:
| Three Months Ended | Six Months Ended | ||||||||||||||||||||||||||||
| December 25, 2022 | September 25, 2022 | December 25, 2022 | December 26, 2021 | ||||||||||||||||||||||||||
| (in thousands) | |||||||||||||||||||||||||||||
| Interest income | $ | 26,125 | $ | 15,056 | $ | 41,181 | $ | 7,050 | |||||||||||||||||||||
| Interest expense | (46,661) | (46,052) | (92,713) | (91,821) | |||||||||||||||||||||||||
| Gains (losses) on deferred compensation plan-related assets, net | 10,871 | (12,726) | (1,855) | 7,381 | |||||||||||||||||||||||||
| Foreign exchange (losses) gains, net | (10,114) | 6,821 | (3,293) | 714 | |||||||||||||||||||||||||
| Other, net | (8,455) | (6,194) | (14,649) | 65,818 | |||||||||||||||||||||||||
| $ | (28,234) | $ | (43,095) | $ | (71,329) | $ | (10,858) | ||||||||||||||||||||||
Interest income increased for the three months ended December 25, 2022 compared to the September 2022 quarter, and the six months ended December 25, 2022, compared to the same period in 2021, primarily because of higher yields partially offset by lower average balances.
Interest expense is consistent across all periods presented.
The gains and losses on deferred compensation plan-related assets were driven by fluctuations in the fair market value of the underlying funds for all periods presented.
Foreign exchange fluctuations were primarily due to currency movements against portions of our unhedged balance sheet exposures for all periods presented.
The losses in other, net for the three and six months ended December 25, 2022, were driven by fluctuations in fair value of equity investments. For the six months ended December 26, 2021, other, net includes an unrealized gain totaling $46.6 million associated with an equity investment that completed a business combination and public offering during that period.
Income Tax Expense
Our provision for income taxes and effective tax rate for the periods indicated were as follows:
| Three Months Ended | Six Months Ended | ||||||||||||||||||||||||||||
| December 25, 2022 | September 25, 2022 | December 25, 2022 | December 26, 2021 | ||||||||||||||||||||||||||
| (in thousands, except percentages) | |||||||||||||||||||||||||||||
| Income tax expense | $ | 183,421 | $ | 228,866 | $ | 412,287 | $ | 324,940 | |||||||||||||||||||||
| Effective tax rate | 11.1 | % | 13.8 | % | 12.5 | % | 12.0 | % |
Lam Research Corporation 2023 Q2 10-Q 25
The decrease in the effective tax rate for the December 2022 quarter compared to the September 2022 quarter was primarily due to the change in level and proportion of income in higher and lower tax jurisdictions in this quarter, recognition of previously unrecognized tax benefits from lapses of statutes of limitation, and a net tax benefit associated with legal entity restructuring.
The increase in the effective tax rate for the six months ended December 25, 2022 compared to the same period in the prior year was primarily due to the change in level and proportion of income in higher and lower tax jurisdictions.
International revenues account for a significant portion of our total revenues, such that a material portion of our pre-tax income is earned and taxed outside the United States. International pre-tax income is taxable in the United States at a lower effective tax rate than the federal statutory tax rate. Please refer to Note 7, “Income Taxes,” to our Consolidated Financial Statements in Part II, Item 8 of our 2022 Form 10-K for additional information.
We re-evaluate uncertain tax positions on a quarterly basis. This evaluation is based on factors including, but not limited to, changes in facts or circumstances, changes in tax law, effectively settled issues under audit, and new audit activity. Any change in recognition or measurement would result in the recognition of a tax benefit or an additional charge to the tax provision.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Refer to our “Critical Accounting Policies and Estimates” included in Part II, Item 7 of our 2022 Form 10-K for a discussion of our critical accounting policies and estimates.
Recent Accounting Pronouncements
For a description of recent accounting pronouncements, including the expected dates of adoption and estimated effects, if any, on our Condensed Consolidated Financial Statements, see Note 2 - Recent Accounting Pronouncements, of our Condensed Consolidated Financial Statements, included in Part 1 of this Form 10-Q.
LIQUIDITY AND CAPITAL RESOURCES
Total gross cash, cash equivalents, investments, and restricted cash and investments balances were $4.8 billion at December 25, 2022 compared to $3.9 billion as of June 26, 2022. This increase was primarily driven by $2,329.8 million of cash generated from operating activities, partially offset by $566.1 million of share repurchases, including net share settlement on employee stock-based compensation; $441.6 million in dividends paid; and $303.4 million of capital expenditures.
Net cash provided by operating activities of $2,329.8 million during the six months ended December 25, 2022, consisted of (in thousands):
| Net income | $ | 2,894,386 | |||
| Non-cash charges: | |||||
| Depreciation and amortization | 161,165 | ||||
| Equity-based compensation expense | 144,194 | ||||
| Deferred income taxes | (140,296) | ||||
| Changes in operating asset and liability accounts | (739,652) | ||||
| Other | 9,978 | ||||
| $ | 2,329,775 | ||||
Significant changes in operating asset and liability accounts, net of foreign exchange impact, included the following uses of cash: increases in inventory of $894.5 million, along with a decrease in trade accounts payable of $116.3 million, accrued expenses and other liabilities of $92.3 million, and deferred profit of $19.9 million. The uses of cash are offset by the following sources of cash: decreases in accounts receivable of $249.1 million, and prepaid expense and other assets of $134.2 million.
Cash Flow from Investing Activities
Net cash used for investing activities during the six months ended December 25, 2022, was $395.1 million, primarily consisting of $303.4 million in capital expenditures and $120.0 million of net cash disbursed for business acquisitions, partially offset by proceeds from maturities of available-for-sale securities of $32.4 million.
Cash Flow from Financing Activities
Net cash used for financing activities during the six months ended December 25, 2022, was $973.2 million, primarily consisting of $566.1 million in treasury stock repurchases, including net share settlement on employee stock-based compensation, and $441.6 million in dividends paid, partially offset by $52.7 million combined proceeds from issuance of common stock.
Lam Research Corporation 2023 Q2 10-Q 26
Liquidity
Given that the semiconductor industry is highly competitive and has historically experienced rapid changes in demand, we believe that maintaining sufficient liquidity reserves is important to support sustaining levels of investment in R&D and capital infrastructure. Anticipated cash flows from operations based on our current business outlook, combined with our current levels of cash, cash equivalents, and short-term investments as of December 25, 2022, are expected to be sufficient to support our anticipated levels of operations, investments, debt service requirements, capital expenditures, capital redistributions, and dividends through at least the next twelve months. However, uncertainty in the global economy and the semiconductor industry, as well as disruptions in credit markets, have in the past, and could in the future, impact customer demand for our products, as well as our ability to manage normal commercial relationships with our customers, suppliers, and creditors.
In the longer term, liquidity will depend to a great extent on our future revenues and our ability to appropriately manage our costs based on demand for our products and services. While we have substantial cash balances, we may require additional funding and need or choose to raise the required funds through borrowings or public or private sales of debt or equity securities. We believe that, if necessary, we will be able to access the capital markets on terms and in amounts adequate to meet our objectives. However, domestic and global macroeconomic and political conditions, or the ongoing COVID-19 pandemic, could cause disruptions to the capital markets and otherwise make any financing more challenging, and there can be no assurance that we will be able to obtain such financing on commercially reasonable terms or at all.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
For financial market risks related to changes in interest rates, marketable equity security prices, and foreign currency exchange rates, refer to Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk”, in our 2022 Form 10-K. Our exposure related to market risk has not changed materially since June 26, 2022.
Item 4. Controls and Procedures
Design of Disclosure Controls and Procedures and Internal Control over Financial Reporting
We maintain disclosure controls and procedures and internal control over financial reporting that are designed to comply with Rule 13a-15 of the Exchange Act. In designing and evaluating the controls and procedures associated with each, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and that the effectiveness of controls cannot be absolute because the cost to design and implement a control to identify errors or mitigate the risk of errors occurring should not outweigh the potential loss caused by the errors that would likely be detected by the control. Moreover, we believe that a control system cannot be guaranteed to be 100% effective all of the time. Accordingly, a control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met.
Disclosure Controls and Procedures
As required by Exchange Act Rule 13a-15(b), as of December 25, 2022, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rule 13a-15(e). Based upon that evaluation, our Chief Executive Officer, along with our Chief Financial Officer, concluded that our disclosure controls and procedures are effective at the reasonable assurance level.
We intend to review and evaluate the design and effectiveness of our disclosure controls and procedures on an ongoing basis and to correct any material deficiencies that we may discover. Our goal is to ensure that our senior management has timely access to material information that could affect our business.
Changes in Internal Control over Financial Reporting
There has been no change in our internal control over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Effectiveness of Controls
While we believe the present design of our disclosure controls and procedures and internal control over financial reporting is effective, future events affecting our business may cause us to modify our disclosure controls and procedures or internal control over financial reporting.
Lam Research Corporation 2023 Q2 10-Q 27
PART II. OTHER INFORMATION
ITEM 1. Legal Proceedings
Please refer to the subsection entitled “Legal Proceedings” within Note 14 “Commitments and Contingencies," to our Condensed Consolidated Financial Statements in this quarterly report on Form 10-Q.
Item 1A. Risk Factors
In addition to the other information in this Form 10-Q, the following risk factors should be carefully considered in evaluating us and our business because such factors may significantly impact our business, operating results, and financial condition. Many of the following risk factors have been, and could be further, exacerbated by the COVID-19 pandemic and any worsening of the global business and economic environment as a result. As a result of these risk factors, as well as other risks discussed in our other SEC filings, our actual results could differ materially from those projected in any forward-looking statements. No priority or significance is intended by, nor should be attached to, the order in which the risk factors appear.
INDUSTRY AND CUSTOMER RISKS
The Semiconductor Capital Equipment Industry Is Subject to Variability and Periods of Rapid Growth or Decline; We Therefore Face Risks Related to Our Strategic Resource Allocation Decisions
The semiconductor capital equipment industry has historically been characterized by rapid changes in demand. The industry environment has moved toward being more characterized by variability across segments and customers, accentuated by consolidation within the industry. Variability in our customers’ business plans may lead to changes in demand for our equipment and services, which could negatively impact our results. The variability in our customers’ investments during any particular period is dependent on several factors, including but not limited to electronics demand, economic conditions (both general and in the semiconductor and electronics industries), industry supply and demand, prices for semiconductors, and our customers’ ability to develop and manufacture increasingly complex and costly semiconductor devices. The changes in demand may require our management to adjust spending and other resources allocated to operating activities.
During periods of rapid growth or decline in demand for our products and services, we face significant challenges in maintaining adequate financial and business controls, management processes, information systems, and procedures for training, assimilating, and managing our workforce, and in appropriately sizing our supply chain infrastructure and facilities, work force, and other components of our business on a timely basis. If we do not adequately meet these challenges during periods of increasing or declining demand, our gross margins and earnings may be negatively impacted. For example, the COVID-19 pandemic has impacted and could in the future impact our ability to meet the demand for our products due to production, sourcing, logistics and other challenges resulting from quarantines, shelter in place or “stay at home” orders, facility closures, workforce challenges, and travel and logistics restrictions in connection with the pandemic.
We continuously reassess our strategic resource allocation choices in response to the changing business environment. If we do not adequately adapt to the changing business environment, we may lack the infrastructure and resources to scale up our business to meet customer expectations and compete successfully during a period of growth, or we may expand our capacity and resources too rapidly and/or beyond what is appropriate for the actual demand environment, resulting in excess fixed costs.
Especially during transitional periods, resource allocation decisions can have a significant impact on our future performance, particularly if we have not accurately anticipated industry changes. Our success will depend, to a significant extent, on the ability of our executive officers and other members of our senior management to identify and respond to these challenges effectively.
Future Declines in the Semiconductor Industry, and the Overall World Economic Conditions on Which It Is Significantly Dependent, Could Have a Material Adverse Impact on Our Results of Operations and Financial Condition
Our business depends on the capital equipment expenditures of semiconductor manufacturers, which in turn depend on the current and anticipated market demand for integrated circuits. With the consolidation of customers within the industry, the semiconductor capital equipment market may experience rapid changes in demand driven both by changes in the market generally and the plans and requirements of particular customers. The economic, political, and business conditions occurring nationally, globally, or in any of our key sales regions, which are often unpredictable, have historically impacted customer demand for our products and normal commercial relationships with our customers, suppliers, and creditors. Additionally, in times of economic uncertainty, our customers’ budgets for our products, or their ability to access credit to purchase them, could be adversely affected. This would limit their ability to purchase our products and services. As a result, changing economic, political or business conditions can cause material adverse changes to our results of operations and financial condition, including but not limited to:
- a decline in demand for our products or services;
Lam Research Corporation 2023 Q2 10-Q 28
-
an increase in reserves on accounts receivable due to our customers’ inability to pay us;
-
an increase in reserves on inventory balances due to excess or obsolete inventory as a result of our inability to sell such inventory;
-
valuation allowances on deferred tax assets;
-
restructuring charges;
-
asset impairments including the potential impairment of goodwill and other intangible assets;
-
a decline in the value of our investments;
-
exposure to claims from our suppliers for payment on inventory that is ordered in anticipation of customer purchases that do not come to fruition;
-
a decline in the value of certain facilities we lease to less than our residual value guarantee with the lessor; and
-
challenges maintaining reliable and uninterrupted sources of supply.
Fluctuating levels of investment by semiconductor manufacturers may materially affect our aggregate shipments, revenues, operating results, and earnings. Where appropriate, we will attempt to respond to these fluctuations with cost management programs aimed at aligning our expenditures with anticipated revenue streams, which sometimes result in restructuring charges. Even during periods of reduced revenues, we must continue to invest in R&D and maintain extensive ongoing worldwide customer service and support capabilities to remain competitive, which may temporarily harm our profitability and other financial results.
We Have a Limited Number of Key Customers
Sales to a limited number of large customers constitute a significant portion of our overall revenue, shipments, cash flows, collections, and profitability. As a result, the actions of even one customer may subject us to variability in those areas that is difficult to predict. In addition, large customers may be able to negotiate requirements that result in decreased pricing, increased costs, and/or lower margins for us; compliance with specific environmental, social, and corporate governance standards; and limitations on our ability to share technology with others. Similarly, significant portions of our credit risk may, at any given time, be concentrated among a limited number of customers so that the failure of even one of these key customers to pay its obligations to us could significantly impact our financial results.
We Face a Challenging and Complex Competitive Environment
We face significant competition from multiple competitors, and with increased consolidation efforts in our industry, as well as the emergence and strengthening of new, regional competitors, we may face increasing competitive pressures. Other companies continue to develop systems and/or acquire businesses and products that are competitive to ours and may introduce new products and product capabilities that may a
Showing the first 8K of 82K characters. Open the full section
Item 5. Other Information
None.
Lam Research Corporation 2023 Q2 10-Q 41
Item 6. Exhibits
| Exhibit Number | Description | ||||
| 10.1* | Form of Restricted Stock Unit Agreement (U.S Participants) - 2015 Stock Incentive Plan | ||||
| 10.2 | Amendment No. 1 to Second Amended and Restated Credit Agreement, dated December 7, 2022, among Lam Research Corporation, as borrower, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent | ||||
| 31.1 | Rule 13a-14(a)/15d-14(a) Certification (Principal Executive Officer) | ||||
| 31.2 | Rule 13a-14(a)/15d-14(a) Certification (Principal Financial Officer) | ||||
| 32.1 | Section 1350 Certification (Principal Executive Officer) | ||||
| 32.2 | Section 1350 Certification (Principal Financial Officer) | ||||
| 101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | ||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | ||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | ||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | ||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | ||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | ||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | ||||
*Indicates management contract or compensatory plan or arrangement.
Lam Research Corporation 2023 Q2 10-Q 42
LAM RESEARCH CORPORATION
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.
| Date: | January 30, 2023 | LAM RESEARCH CORPORATION (Registrant) | |||||||||
| /s/ Douglas R. Bettinger | |||||||||||
| Douglas R. Bettinger | |||||||||||
| Executive Vice President, Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |
Lam Research Corporation 2023 Q2 10-Q 43